Skip to main content
Top
Published in: Rheumatology International 3/2013

01-03-2013 | Original Article

Capillaroscopic pattern in systemic lupus erythematosus and undifferentiated connective tissue disease: What we still have to learn?

Authors: Sevdalina Nikolova Lambova, Ulf Müller-Ladner

Published in: Rheumatology International | Issue 3/2013

Login to get access

Abstract

In rheumatology, specific is the capillaroscopic pattern in systemic sclerosis (SSc), the so-called “scleroderma type”. Capillaroscopic pattern in systemic lupus erythematosus (SLE) is less specific and includes a wide range of microvascular changes—“SLE-type” capillaroscopic pattern, non-specific findings and in a small percentage “scleroderma-like” pattern. The latter finding is currently associated with a potential subclinical overlap with SSc. Various microvascular changes have been observed in a different proportion of patients with undifferentiated connective tissue disease (UCTD). The aim of the study was to evaluate the capillaroscopic changes in SLE and UCTD. Patients from the following groups were included in the study: 30 female patients with SLE (mean age, 49 ± 15.4 years), 31 patients with UCTD (mean age, 50 ± 17 years; 30 females and 1 male); 34 age- and sex-matched healthy volunteers were examined as a control group. Nailfold capillaroscopy was performed using videocapillaroscope Videocap 3.0 (DS Medica). Capillaroscopic findings were compared with clinical and laboratory data of the patients. At capillaroscopic examination, the most frequent capillaroscopic changes in SLE patients were the presence of elongated capillaries in 43 % (13/30), an increased tortuosity in 70 % (21/30) and a prominent subpapillary plexus in 60 % (18/30) of the cases. In 80 % (24/30) of the patients, dilated capillaries were found; in 6.6 % (2/30), giant capillary loops; and in 16.6 % (5/30), haemorrhages. In 50 % of the patients, an “SLE-type” capillaroscopic pattern was found. In 30 % (9/30) of the cases the capillaroscopic examination revealed “non-specific changes”, in 6.6 % (2/30) of the patients it was found a normal capillaroscopic pattern and in 13.3 % (4/30) a “scleroderma-like” pattern. Positive tests for ANA were detected in 73.3 % (11/15) of the patients with “SLE-type” capillaroscopic pattern. In all the patients with “scleroderma-like” capillaroscopic finding, positive autoantibodies with a high titre were found, without signs for overlap with other connective tissue disease (CTD). In two out of four patients with such capillaroscopic findings, a vasculitis of peripheral vessels was evident and in the other two secondary RP and high immunologic activity. A “scleroderma-like” pattern was found in 38 % (12/31) of the patients with UCTD. In 51 % (16/31) of the patients from this group, “non-specific” capillaroscopic findings were observed. For the evaluation of the predictive value of capillaroscopic pattern for the development of a distinct rheumatic disorder in patients with UCTD, a longer period of follow-up is necessary. In SLE patients, it has been found that capillaroscopic examination reveals microvascular changes also in the absence of RP. Here, the results from the study illustrate the correlation between capillaroscopic changes and immunological profile. “Scleroderma-like” capillaroscopic pattern may be observed in the context of active vasculitis of peripheral vessels as well as in patients with secondary RP and high immunologic activity. It does not have an obligatory association with an overlap syndrome with other CTD. Capillaroscopic findings in UCTD are heterogeneous. The potential of capillaroscopic examination in UCTD for evaluating the prognosis of the disease needs to be revealed through long-term follow-up.
Literature
1.
go back to reference Beltran E, Toll A, Pros A, Carbonell J, Pujol RM (2007) Assessment of nailfold capillaroscopy by x30 digital epiluminiscence (dermoscopy) in patients with Raynaud’s phenomenon. Clin Lab Invest 156:892–898 Beltran E, Toll A, Pros A, Carbonell J, Pujol RM (2007) Assessment of nailfold capillaroscopy by x30 digital epiluminiscence (dermoscopy) in patients with Raynaud’s phenomenon. Clin Lab Invest 156:892–898
2.
go back to reference Bollinger A, Fagrell B, (1990) Clinical capillaroscopy—a guide to its use in clinical research and practice. Hogrefe & Huber Publishers, Toronto, pp 1–123 Bollinger A, Fagrell B, (1990) Clinical capillaroscopy—a guide to its use in clinical research and practice. Hogrefe & Huber Publishers, Toronto, pp 1–123
3.
go back to reference Cortes S, Cutolo M (2007) Capillaroscopic patterns in rheumatic diseases. Acta Reum Port 32:29–36 Cortes S, Cutolo M (2007) Capillaroscopic patterns in rheumatic diseases. Acta Reum Port 32:29–36
4.
go back to reference Cutolo M, Grassi W, Matucci Cerinic M (2003) Raynaud’s phenomenon and the role of capillaroscopy. Arthritis Rheum 48(11):3023–3030PubMedCrossRef Cutolo M, Grassi W, Matucci Cerinic M (2003) Raynaud’s phenomenon and the role of capillaroscopy. Arthritis Rheum 48(11):3023–3030PubMedCrossRef
5.
go back to reference Cutolo M, Sulli A, Pizzorni C, Accardo S (2000) Nailfold videocapillaroscopy assessment of microvascular damage in systemic sclerosis. J Rheumatol 27:155–160PubMed Cutolo M, Sulli A, Pizzorni C, Accardo S (2000) Nailfold videocapillaroscopy assessment of microvascular damage in systemic sclerosis. J Rheumatol 27:155–160PubMed
6.
go back to reference Cutolo M, Pizzorni C, Tuccio M, Burroni A, Craviotto C, Basso M et al (2004) Nailfold videocapillaroscopic patterns and serum autoantibodies in systemic sclerosis. Rheumatology (Oxford) 43:719–726CrossRef Cutolo M, Pizzorni C, Tuccio M, Burroni A, Craviotto C, Basso M et al (2004) Nailfold videocapillaroscopic patterns and serum autoantibodies in systemic sclerosis. Rheumatology (Oxford) 43:719–726CrossRef
7.
8.
go back to reference Maricq HR, Le Roy EC, D’Angelo WA, Medsger TA Jr, Rodnan GP, Sharp GC, Wolfe JF (1980) Diagnostic potential of in vivo capillary microscopy in scleroderma and related disorders. Arthritis Rheum 23(2):183–189PubMedCrossRef Maricq HR, Le Roy EC, D’Angelo WA, Medsger TA Jr, Rodnan GP, Sharp GC, Wolfe JF (1980) Diagnostic potential of in vivo capillary microscopy in scleroderma and related disorders. Arthritis Rheum 23(2):183–189PubMedCrossRef
9.
go back to reference Maricq HR, Harper FE, Khan MM, Tan EM, LeRoy EC (1983) Microvascular abnormalities as possible predictors of disease subsets in Raynaud phenomenon and early connective tissue disease. Clin Exp Rheumatol 1(3):195–205PubMed Maricq HR, Harper FE, Khan MM, Tan EM, LeRoy EC (1983) Microvascular abnormalities as possible predictors of disease subsets in Raynaud phenomenon and early connective tissue disease. Clin Exp Rheumatol 1(3):195–205PubMed
10.
go back to reference Maricq HR (1986) Comparison of quantitative and semiquantitative estimates of nailfold capillary abnormalities in scleroderma spectrum disorders. Microvasc Res 32(2):271–276PubMedCrossRef Maricq HR (1986) Comparison of quantitative and semiquantitative estimates of nailfold capillary abnormalities in scleroderma spectrum disorders. Microvasc Res 32(2):271–276PubMedCrossRef
11.
go back to reference Maricq HR, Valter I (2004) A working classification of scleroderma spectrum disorders: a proposal and the results of testing on a sample of patients. Clin Exp Rheumatol 22(3 Suppl 33):S5–S13PubMed Maricq HR, Valter I (2004) A working classification of scleroderma spectrum disorders: a proposal and the results of testing on a sample of patients. Clin Exp Rheumatol 22(3 Suppl 33):S5–S13PubMed
12.
go back to reference Nagy Z, Czirjac L (2004) Nailfold digital capillaroscopy in 447 patients with connective tissue disease and Raynaud’s disease. J Europ Acad Dermatol Venerol 18:62–68CrossRef Nagy Z, Czirjac L (2004) Nailfold digital capillaroscopy in 447 patients with connective tissue disease and Raynaud’s disease. J Europ Acad Dermatol Venerol 18:62–68CrossRef
13.
go back to reference Block JA, Sequeira W (2001) Raynaud’s phenomenon. Seminar Lancet 357:2042–2048CrossRef Block JA, Sequeira W (2001) Raynaud’s phenomenon. Seminar Lancet 357:2042–2048CrossRef
14.
go back to reference Kirou KA, Crow MK (2000) Raynaud’s phenomenon. In Paget SA et al Manual of rheumatology and outpatient orthopedic disorders: diagnosis and therapy, 4th ed. Lippincot Williams & Willkins, Philadelphia, pp 82–87 Kirou KA, Crow MK (2000) Raynaud’s phenomenon. In Paget SA et al Manual of rheumatology and outpatient orthopedic disorders: diagnosis and therapy, 4th ed. Lippincot Williams & Willkins, Philadelphia, pp 82–87
15.
go back to reference Dancour MA, Vaz JL, Bottino DA, Bouskela E (2006) Nailfold videocapillaroscopy in patients with systemic lupus erythematosus. Rheumatol Int 26(7):633–637PubMedCrossRef Dancour MA, Vaz JL, Bottino DA, Bouskela E (2006) Nailfold videocapillaroscopy in patients with systemic lupus erythematosus. Rheumatol Int 26(7):633–637PubMedCrossRef
16.
go back to reference Lefford F, Edwards JCW (1986) Nailfold capillary microscopy in connective tissue disease: a quantitative morphological analysis. Ann Rheum Dis 45:741–749PubMedCrossRef Lefford F, Edwards JCW (1986) Nailfold capillary microscopy in connective tissue disease: a quantitative morphological analysis. Ann Rheum Dis 45:741–749PubMedCrossRef
17.
go back to reference Redisch W (1970) Capillaroscopic observations in rheumatic diseases. Ann Reum Dis 29:244–253CrossRef Redisch W (1970) Capillaroscopic observations in rheumatic diseases. Ann Reum Dis 29:244–253CrossRef
18.
go back to reference Granier F, Priollet P, Housset E (1986) Nailfold capillary microscopy in mixed connective tissue disease. Comparison with systemic sclerosis and systemic lupus erythematosus. Arthritis Rheum 29(2):189–195PubMedCrossRef Granier F, Priollet P, Housset E (1986) Nailfold capillary microscopy in mixed connective tissue disease. Comparison with systemic sclerosis and systemic lupus erythematosus. Arthritis Rheum 29(2):189–195PubMedCrossRef
19.
go back to reference Kabasakal Y, Elvins DM, Ring EF, McHugh NJ (1996) Quantitative nailfold capillaroscopy findings in a population with connective tissue disease and in normal healthy controls. Ann Rheum Dis 55:507–512PubMedCrossRef Kabasakal Y, Elvins DM, Ring EF, McHugh NJ (1996) Quantitative nailfold capillaroscopy findings in a population with connective tissue disease and in normal healthy controls. Ann Rheum Dis 55:507–512PubMedCrossRef
20.
go back to reference Bergman R, Sharony L, Schapira D, Nahir MA, Balbir-Gurman A (2003) The handheld dermatoscope as a nail-fold capillaroscopic instrument. Arch Dermatol 139:1027–1030PubMedCrossRef Bergman R, Sharony L, Schapira D, Nahir MA, Balbir-Gurman A (2003) The handheld dermatoscope as a nail-fold capillaroscopic instrument. Arch Dermatol 139:1027–1030PubMedCrossRef
21.
go back to reference Furtado RNV, Pucinell MLC, Cristo VV, Andrade LEC, Sato EI (2002) Scleroderma-like nailfold capillaroscopic abnormalities are associated with anti-U1-RNP antibodies and Raynaud’s phenomenon in SLE patients. Lupus 11(1):35–41PubMedCrossRef Furtado RNV, Pucinell MLC, Cristo VV, Andrade LEC, Sato EI (2002) Scleroderma-like nailfold capillaroscopic abnormalities are associated with anti-U1-RNP antibodies and Raynaud’s phenomenon in SLE patients. Lupus 11(1):35–41PubMedCrossRef
22.
go back to reference Groen H, ter Borg EJ, Postma DS, Wouda AA, van der Mark TW, Kallenberg CG (1992) Pulmonary function in systemic lupus erythematosus is related to distinct clinical, serologic, and nailfold capillary patterns. Am L Med 93(6):619–627CrossRef Groen H, ter Borg EJ, Postma DS, Wouda AA, van der Mark TW, Kallenberg CG (1992) Pulmonary function in systemic lupus erythematosus is related to distinct clinical, serologic, and nailfold capillary patterns. Am L Med 93(6):619–627CrossRef
23.
go back to reference Ingegnoli F, Zeni S, Meani L, Soldi A, Lurati A, Fantini F (2005) Evaluation of nailfold videocapillaroscopic abnormalities in patients with systemic lupus erythematosus. J Clin Rheumatol 11(6):295–298PubMedCrossRef Ingegnoli F, Zeni S, Meani L, Soldi A, Lurati A, Fantini F (2005) Evaluation of nailfold videocapillaroscopic abnormalities in patients with systemic lupus erythematosus. J Clin Rheumatol 11(6):295–298PubMedCrossRef
24.
go back to reference Bongard O, Bounameaux H, Miescher PA, De Moerloose P (1995) Association of anticardiolipin antibodies and abnormal nailfold capillaroscopy in patients with systemic lupus erythematosus. Lupus 4(2):142–144PubMedCrossRef Bongard O, Bounameaux H, Miescher PA, De Moerloose P (1995) Association of anticardiolipin antibodies and abnormal nailfold capillaroscopy in patients with systemic lupus erythematosus. Lupus 4(2):142–144PubMedCrossRef
25.
go back to reference Riccieri V, Spadaro A, Ceccarelli F, Scrivio R, Germano V, Valesini G (2005) Nailfold capillaroscopy changes in systemic lupus erythematosus: correlation with disease activity and autoantibody profile. Lupus 14:521–525PubMedCrossRef Riccieri V, Spadaro A, Ceccarelli F, Scrivio R, Germano V, Valesini G (2005) Nailfold capillaroscopy changes in systemic lupus erythematosus: correlation with disease activity and autoantibody profile. Lupus 14:521–525PubMedCrossRef
26.
go back to reference Asherson RA, Pierangeli SS, Cervera R (2007) Is there a miroangiopathic antiphospholipid syndrome? Ann Rheum Dis 66:429–432PubMedCrossRef Asherson RA, Pierangeli SS, Cervera R (2007) Is there a miroangiopathic antiphospholipid syndrome? Ann Rheum Dis 66:429–432PubMedCrossRef
27.
go back to reference Pallis M, Hopkinson N, Powell R (1991) Nailfold capillary density as a possible indicator of pulmonary capillary loss in systemic lupus erythematosus but not in mixed connective tissue disease. J Rheumatol 18(10):1532–1536PubMed Pallis M, Hopkinson N, Powell R (1991) Nailfold capillary density as a possible indicator of pulmonary capillary loss in systemic lupus erythematosus but not in mixed connective tissue disease. J Rheumatol 18(10):1532–1536PubMed
28.
go back to reference Tan EM, Cohen AS, Fries JF, Masi AT, McShane DJ, Rothfield NF et al (1982) The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 25:1271–1277PubMedCrossRef Tan EM, Cohen AS, Fries JF, Masi AT, McShane DJ, Rothfield NF et al (1982) The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 25:1271–1277PubMedCrossRef
29.
go back to reference Schmidt JA, Caspary L, von Bierbrauer A, Ehrly AM, Jünger M, Jung F, Lawall H (1997) Standardisierung der Nagelfalz-Kapillarmikroskopie in der Routinediagnostik. Vasa 25:5–10 Schmidt JA, Caspary L, von Bierbrauer A, Ehrly AM, Jünger M, Jung F, Lawall H (1997) Standardisierung der Nagelfalz-Kapillarmikroskopie in der Routinediagnostik. Vasa 25:5–10
Metadata
Title
Capillaroscopic pattern in systemic lupus erythematosus and undifferentiated connective tissue disease: What we still have to learn?
Authors
Sevdalina Nikolova Lambova
Ulf Müller-Ladner
Publication date
01-03-2013
Publisher
Springer-Verlag
Published in
Rheumatology International / Issue 3/2013
Print ISSN: 0172-8172
Electronic ISSN: 1437-160X
DOI
https://doi.org/10.1007/s00296-012-2434-0

Other articles of this Issue 3/2013

Rheumatology International 3/2013 Go to the issue
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.